{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:11:27Z","timestamp":1770894687932,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Accuray Inc. A.C. Tree"},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.clon.2018.05.001","type":"journal-article","created":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T10:48:27Z","timestamp":1527245307000},"page":"539-547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["An Investigation of Dosimetric Correlates of Acute Toxicity in Prostate Stereotactic Body Radiotherapy: Dose to Urinary Trigone is Associated with Acute Urinary Toxicity"],"prefix":"10.1016","volume":"30","author":[{"given":"D.R.","family":"Henderson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.R.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.L.","family":"Gulliford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.C.","family":"Tree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.J.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.J.","family":"Van As","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clon.2018.05.001_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.clon.2015.01.011","article-title":"Stereotactic body radiotherapy for prostate cancer","volume":"27","author":"Henderson","year":"2015","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2018.05.001_bib2","series-title":"Prostate advance in comparative evidence (PACE) - NCT01584258","author":"ClinicalTrials.gov","year":"2017"},{"issue":"2","key":"10.1016\/j.clon.2018.05.001_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.radonc.2009.08.004","article-title":"Dose-volume effects for normal tissues in external radiotherapy: pelvis","volume":"93","author":"Fiorino","year":"2009","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.clon.2018.05.001_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.radonc.2010.08.002","article-title":"The relationship between external beam radiotherapy dose and chronic urinary dysfunction \u2013 a methodological critique","volume":"97","author":"Rosewall","year":"2010","journal-title":"Radiother Oncol"},{"issue":"21","key":"10.1016\/j.clon.2018.05.001_bib5","doi-asserted-by":"crossref","first-page":"6535","DOI":"10.1088\/0031-9155\/54\/21\/006","article-title":"Assessing correlations between the spatial distribution of the dose to the rectal wall and late rectal toxicity after prostate radiotherapy: an analysis of data from the MRC RT01 trial (ISRCTN 47772397)","volume":"54","author":"Buettner","year":"2009","journal-title":"Phys Med Biol"},{"issue":"2","key":"10.1016\/j.clon.2018.05.001_bib6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijrobp.2013.10.042","article-title":"Impact of dose to the bladder trigone on long-term urinary function after high-dose intensity modulated radiation therapy for localized prostate cancer","volume":"88","author":"Ghadjar","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.clon.2018.05.001_bib7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ijrobp.2014.03.012","article-title":"Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer","volume":"89","author":"Kim","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2018.05.001_bib8","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.clon.2014.08.007","article-title":"Prostate stereotactic body radiotherapy - first UK experience","volume":"26","author":"Tree","year":"2014","journal-title":"Clin Oncol"},{"issue":"1","key":"10.1016\/j.clon.2018.05.001_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijrobp.2006.03.055","article-title":"Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: consequential late damage","volume":"66","author":"Heemsbergen","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.clon.2018.05.001_bib10","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1470-2045(15)00567-7","article-title":"Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial","volume":"17","author":"Aluwini","year":"2016","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.clon.2018.05.001_bib11","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.ijrobp.2009.09.011","article-title":"Predicting late effects of pelvic radiotherapy: is there a better approach?","volume":"78","author":"Wedlake","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.clon.2018.05.001_bib12","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.clon.2016.04.041","article-title":"Acute and late genitourinary toxicity after 72 Gy of conventionally fractionated conformal radiotherapy for localised prostate cancer: impact of individual and clinical parameters","volume":"28","author":"Stankovic","year":"2016","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2018.05.001_bib13","series-title":"Bladder and trigone surface doses are related to acute urinary toxicity in focally dose-escalated prostate IMRT","author":"Murray","year":"2015"},{"issue":"8","key":"10.1016\/j.clon.2018.05.001_bib14","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: the report of AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"issue":"1","key":"10.1016\/j.clon.2018.05.001_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.radonc.2014.06.009","article-title":"Dosimetric and patient correlates of quality of life after prostate stereotactic ablative radiotherapy","volume":"112","author":"Elias","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2018.05.001_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clon.2017.09.007","article-title":"UK consensus on normal tissue dose constraints for stereotactic radiotherapy","volume":"30","author":"Hanna","year":"2018","journal-title":"Clin Oncol"},{"issue":"5","key":"10.1016\/j.clon.2018.05.001_bib17","first-page":"1770","article-title":"Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?","volume":"154","author":"Barry","year":"1995","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.clon.2018.05.001_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijrobp.2009.07.1680","article-title":"Urinary obstruction in prostate cancer patients from the Dutch trial (68 Gy vs. 78 Gy): relationships with local dose, acute effects, and baseline characteristics","volume":"78","author":"Heemsbergen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.clon.2018.05.001_bib19","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ijrobp.2014.06.031","article-title":"Dose to the bladder neck is the most important predictor for acute and late toxicity after low-dose-rate prostate brachytherapy: implications for establishing new dose constraints for treatment planning","volume":"90","author":"Hathout","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.clon.2018.05.001_bib20","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.eururo.2008.06.048","article-title":"Characteristics of spontaneous activity in the bladder trigone","volume":"56","author":"Roosen","year":"2009","journal-title":"Eur Urol"},{"issue":"1054","key":"10.1016\/j.clon.2018.05.001_bib21","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150243","article-title":"Accumulated dose to the rectum, measured using dose-volume histograms and dose-surface maps, is different from planned dose in all patients treated with radiotherapy for prostate cancer","volume":"88","author":"Scaife","year":"2015","journal-title":"Br J Radiol"},{"key":"10.1016\/j.clon.2018.05.001_bib22","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.radonc.2015.10.020","article-title":"Dose-surface maps identifying local dose-effects for acute gastrointestinal toxicity after radiotherapy for prostate cancer","volume":"117","author":"Wortel","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2018.05.001_bib23","first-page":"844","article-title":"Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer","volume":"82","author":"King","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655518302425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655518302425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:45:06Z","timestamp":1760543106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655518302425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0936655518302425"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2018.05.001","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Investigation of Dosimetric Correlates of Acute Toxicity in Prostate Stereotactic Body Radiotherapy: Dose to Urinary Trigone is Associated with Acute Urinary Toxicity","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2018.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}